Entrada Therapeutics Inc (TRDA) — Financial Flexibility Index
Entrada Therapeutics Inc (TRDA) has a Financial Flexibility Index of -0.39x as of September 2025. Free cash flow of $-28.14 Million (operating CF $-28.31 Million minus capex $171.00K) represents 0% of total liabilities ($72.18 Million). Check Entrada Therapeutics Inc (TRDA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Entrada Therapeutics Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Entrada Therapeutics Inc across 6 annual periods. For the full cash flow conversion analysis, see TRDA cash generation efficiency.
Annual Financial Flexibility Index for Entrada Therapeutics Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Entrada Therapeutics Inc. Explore Entrada Therapeutics Inc (TRDA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.39x | $-38.40 Million | $-41.56 Million | $97.64 Million | ▼ -161.3% |
| 2023 | 0.64x | $145.42 Million | $139.80 Million | $226.83 Million | ▲ +127.9% |
| 2022 | -2.30x | $-90.90 Million | $-93.79 Million | $39.50 Million | ▲ +64.6% |
| 2021 | -6.50x | $-46.28 Million | $-50.86 Million | $7.12 Million | ▼ -2278.4% |
| 2020 | -0.27x | $-23.25 Million | $-25.57 Million | $85.02 Million | ▲ +9.2% |
| 2019 | -0.30x | $-10.17 Million | $-10.80 Million | $33.76 Million | — |